Comparison the rate of acue transplant rejection and side effect of therapy with and without thymoglobuline in kidney transplantation

Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobuline and standard therapy in kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017050933884N1

Enrollment

106

Registered

2017-06-03

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation status. kidney transplant status

Interventions

Intervention 1: standard therapy and Induction therapy with Thymoglobulin. Intervention 2: Standard therapy without thymoglobulin.

Treatment - Drugs

standard therapy and Induction therapy with Thymoglobulin

Standard therapy without thymoglobulin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria : all the patients who are tranplanted in golestan hospital Exclusion criteria : donor and recipient full-matched HLA; contraindication for administration of thymoglobulin; peresence of organ transplantation other than the kidney

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Glomrular Filtration Rate. Timepoint: Monthly. Method of measurement: cc per minute,MDRD equation.	—

Secondary

Measure	Time frame
Side Effects of Medications. Timepoint: Monthly. Method of measurement: Questionnarire and Lab data.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSabetnia Leila

Golestan Hospital

sabetnia-l@ajums.ac.ir+98 61 3441 2263

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026